378 related articles for article (PubMed ID: 35984514)
1. Multicenter clinical radiomics-integrated model based on [
Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
[TBL] [Abstract][Full Text] [Related]
3. Multivariate radiomics models based on
Hu X; Sun X; Hu F; Liu F; Ruan W; Wu T; An R; Lan X
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3469-3481. PubMed ID: 33829415
[TBL] [Abstract][Full Text] [Related]
4. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
[TBL] [Abstract][Full Text] [Related]
5. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
6. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
[TBL] [Abstract][Full Text] [Related]
7. An Integrated Radiomics Model Incorporating Diffusion-Weighted Imaging and
Zhang L; Yao R; Gao J; Tan D; Yang X; Wen M; Wang J; Xie X; Liao R; Tang Y; Chen S; Li Y
Front Oncol; 2021; 11():732704. PubMed ID: 34527594
[TBL] [Abstract][Full Text] [Related]
8. A fusion model integrating magnetic resonance imaging radiomics and deep learning features for predicting alpha-thalassemia X-linked intellectual disability mutation status in isocitrate dehydrogenase-mutant high-grade astrocytoma: a multicenter study.
Liu Z; Xu X; Zhang W; Zhang L; Wen M; Gao J; Yang J; Kan Y; Yang X; Wen Z; Chen S; Cao X
Quant Imaging Med Surg; 2024 Jan; 14(1):251-263. PubMed ID: 38223098
[TBL] [Abstract][Full Text] [Related]
9. An [
Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.
Zhou W; Wen J; Huang Q; Zeng Y; Zhou Z; Zhu Y; Chen L; Guan Y; Xie F; Zhuang D; Hua T
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1423-1435. PubMed ID: 38110710
[TBL] [Abstract][Full Text] [Related]
11. ATRX status in patients with gliomas: Radiomics analysis.
Meng L; Zhang R; Fa L; Zhang L; Wang L; Shao G
Medicine (Baltimore); 2022 Sep; 101(37):e30189. PubMed ID: 36123880
[TBL] [Abstract][Full Text] [Related]
12. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
Tatekawa H; Yao J; Oughourlian TC; Hagiwara A; Wang C; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Salamon N; Ellingson BM
Clin Nucl Med; 2020 Dec; 45(12):e505-e511. PubMed ID: 33031233
[TBL] [Abstract][Full Text] [Related]
13. Static
Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
15. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
[TBL] [Abstract][Full Text] [Related]
16. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
[TBL] [Abstract][Full Text] [Related]
18. Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study.
Li Z; Zhang J; Zhong Q; Feng Z; Shi Y; Xu L; Zhang R; Yu F; Lv B; Yang T; Huang C; Cui F; Chen F
Eur Radiol; 2023 Mar; 33(3):1835-1843. PubMed ID: 36282309
[TBL] [Abstract][Full Text] [Related]
19. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
20. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L
J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
